Combination of anti-CTLA4 antibodies with gemcitabine for the synergistic treatment of proliferative diseases
- 专利权人:
- Bristol-Myers Squibb Company
- 发明人:
- LEE, Francis,JURE-KUNKEL, Maria
- 申请号：
- ES15166232
- 公开号：
- ES2768990T3
- 申请日:
- 2009.10.29
- 申请国别(地区):
- ES
- 年份:
- 2020
- 代理人:
- 摘要：
- Compositions and methods are disclosed which are useful of the treatment and prevention of proliferative disorders.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- COMBINATION OF ANTI-CTLA4 ANTIBODY WITH GEMCITABINE FOR THE SYNERGISTIC TREATMENT OF PROLIFERATIVE DISEASES
- COMBINATION OF ANTI-CTLA4 ANTIBODY WITH DIVERSE THERAPEUTIC REGIMENS FOR THE SYNERGISTIC TREATMENT OF PROLIFERATIVE DISEASES
- COMBINATION OF ANTI-CTLA4 ANTIBODY WITH TUBULIN MODULATING AGENTS FOR THE TREATMENT OF PROLIFERATIVE DISEASES
- COMBINATION OF ANTI-CTLA4 ANTIBODY WITH DIVERSE THERAPEUTIC REGIMENS FOR THE SYNERGISTIC TREATMENT OF PROLIFERATIVE DISEASES
- Combination of anti-CTLA4 antibody and various therapeutic regimens for synergistic treatment of proliferative diseases
